多款 FIC 生物新药首发 AACR !来自阿斯利康、GSK、信达...

Insight数据库
Yesterday

2025 年 AACR 火热进行中。这次大会上,差不多有 50 款 FIC 生物新药首发亮相。具体都有什么呢?我们一起来看一下。另外,视频结尾有完整清单,记得保存哦。先说说 MNC,阿斯利康在大会上首次公布了一款前列腺癌 TCE 疗法(AZD6621)的临床前研究数据。这款产品用 3 种方式提高了治疗指数,包括瞄准新靶点(STEAP2),优化 CD3 结合域的亲和力,以及整合 CD8 结合域。据说...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10